Ivor Lewis esophagectomy surgery performed at Mater Townsville
25 March, 2022The minimally invasive Ivor Lewis esophagectomy surgery has been successfully performed on a patient at Mater Private Hospital Townsville.
How deceased ovarian cancer patients are safeguarding their families' health
21 March, 2022A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
Breast cancer: how often does overdiagnosis occur?
02 March, 2022A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
Liver cancer: non-invasive treatment trial to begin soon
25 February, 2022A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Cervical screening tests could help detect ovarian, breast cancers
02 February, 2022Cervical screening tests could be used to find ovarian and breast cancers, according to international researchers.
Program improves return-to-work outcomes for cancer survivors
19 January, 2022A digital health program by CancerAid and AIA Australia has demonstrated improved return-to-work outcomes for cancer survivors.
Sparking innovation in cancer research
14 October, 2021 by Jane AllmanProfessor Mark Dawson's research has identified novel therapeutic strategies for several cancers and has helped to establish clinical trials with epigenetic therapies.
Breast cancer: alcohol, weight gain lead to rise in rates; 1 in 4 cases preventable
06 October, 2021Breast cancer rates have increased by 50% since the 1980s due to increased alcohol consumption, weight gain, a lack of exercise and other lifestyle factors.
Opinion: How precision oncology is transforming patient care
30 September, 2021 by Professor David Thomas, Director of the Kinghorn Cancer Centre and Lab Head of Genomic Cancer Medicine at the Garvan Institute of Medical Research AustraliaCancer is fundamentally a genetic disease, driven by mutations that drive cancer growth. Just as each person is genetically unique, so the genomic profile of no two cancers is the same.
Pancreatic cancer: new service trial to support carers
16 September, 2021PanKind and QIMR Berghofer Medical Research Institute have teamed up to trial a new service to support carers through the devastating impact of pancreatic cancer.
Scalp cooling lets 1 in 2 women keep hair during chemo
22 July, 2021Cancer experts are calling for greater access to advanced scalp-cooling technology for women undergoing chemotherapy in a bid to reduce the impact of treatment-related hair loss.
New treatment for asbestos-related cancer
01 July, 2021Australians living with inoperable malignant mesothelioma will soon have access to an immunotherapy listed on the Pharmaceutical Benefits Scheme.
PanKind initiative sets sights on early detection of pancreatic cancer
21 June, 2021PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.
New cancer centre to offer cutting-edge radiation therapy services
14 May, 2021A state-of-the-art cancer centre is scheduled to open within Holmesglen Private Hospital in September this year, offering the latest in advanced radiation therapy.
Breast implant cancer risk warning
11 May, 2021Victorian women who have undergone breast implant or breast reconstructive procedures are being encouraged to watch for early symptoms of a rare form of cancer.
